EMA Authorised: Firdapse (previously Zenas) (amifampridine) — SERB SA

View source ↗

Summary

The European Medicines Agency authorised Firdapse (amifampridine) for the treatment of Lambert-Eaton Myasthenic Syndrome. The marketing authorization holder is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lambert-eaton Myasthenic Syndrome

Drugs mentioned

• FIRDAPSE (AMIFAMPRIDINE PHOSPHATE)

Snippet

Status: Authorised. Therapeutic area: Lambert-Eaton Myasthenic Syndrome. MAH: SERB SA. Decision date: 22/07/2021